You just read:

FDA accepts for review Supplemental Biologics License Application for 0.5 mL dose of Fluzone® Quadrivalent (Influenza Vaccine) in children 6-35 months of age

News provided by

Sanofi

Apr 25, 2018, 09:05 ET